Relatient has been sold to Brighton Park Capital
Client: Relatient, LLC
Client Location: United States
Target: Relatient, LLC
Target Location: United States
Acquirer: Brighton Park Capital Management, L.P.
Acquirer Location: United States
Target Description: Relatient is the leading customer-rated patient engagement vendor.
“Elsewhere Partners is proud to have partnered with Michele and the team at Relatient. The company has grown tremendously in the short time since Elsewhere has been an investor, and we are extremely pleased with the outcome that the team at Lincoln achieved for the company and investors,” commented John Thornton, Co-founder and Partner at Elsewhere Partners.
“It has been truly rewarding to watch Relatient grow from an early-stage company into the category leader it is today,” said Jim Sohr, Founder and Chairman of Powered Health and one of Relatient’s earliest investors. “The team at Lincoln ran an extremely efficient process and achieved a great outcome for shareholders and the company. I am looking forward to tracking Relatient’s continued market leadership under Brighton Park’s ownership.”
“After driving a successful outcome for Michele on Unanet, we were thrilled to do the same for her on Relatient,” said Clark Spurrier, Managing Director at Lincoln. “Our team was very excited to have served as an integral part of the next phase of Relatient’s journey.
“Relatient’s comprehensive patient engagement platform enables providers to improve communication, productivity and ultimately deliver better patient care,” said Derek Ritchea, Managing Director at Lincoln. “We couldn’t be happier for Michele, Patrick and the entire Relatient team as they begin their relationship with Brighton Park Capital. This partnership and additional growth investment will strengthen Relatient’s market-leading position and enable the company to continue their rapid growth in the patient engagement sector.”
Meet our Senior Team
View More Transactions in Technology, Media & Telecom and Healthcare
Lincoln International advised SiXworks on receiving significant investment from Chiltern Capital
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Palisade Software, a portfolio company of Thompson Street Capital Partners, on the sale of TA Associates and combined with Lumivero
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.